Mintun, Mark A.
Eli Lilly and Company,
United States
2025 Rank: 25125
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1894 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25125 | 26784 |
| Total Cites | 51547 | 58701 |
| H-index | 108 | 116 |
| Hm-index | 25 | 25 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 3705 | 4082 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 15226 | 16546 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 39316 | 42534 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.38 |
| Self-Citation Percentage |
12.19%
|
|
Mintun, Mark A.
Washington University in St. Louis,
United States
2024 Rank: 24691
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1898 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24691 | 26400 |
| Total Cites | 47317 | 53774 |
| H-index | 105 | 113 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 3327 | 3692 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 14108 | 15327 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 36221 | 39149 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
12.01%
|
|
Mintun, Mark A.
Eli Lilly and Company,
United States
2023 Rank: 24440
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1913 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24440 | 26128 |
| Total Cites | 43868 | 49754 |
| H-index | 100 | 109 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 3033 | 3379 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 13133 | 14257 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 33631 | 36320 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.37 |
| Self-Citation Percentage |
11.83%
|
|
Mintun, Mark A.
Washington University in St. Louis,
United States
2022 Rank: 24720
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1962 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24720 | 26676 |
| Total Cites | 40086 | 45277 |
| H-index | 96 | 102 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 2697 | 3021 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 12035 | 13037 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30801 | 33193 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
11.46%
|
|
Mintun, Mark A.
Avid Radiopharmaceuticals, Inc,
United States
2021 Rank: 24111
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1899 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24111 | 26093 |
| Total Cites | 38398 | 43294 |
| H-index | 94 | 100 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 2557 | 2870 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 11531 | 12496 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29518 | 31751 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
11.31%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.